Skip to main content
Erschienen in: Clinical Rheumatology 5/2017

26.04.2016 | Original Article

Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients—signs of volume overload

verfasst von: Rainer H. Straub, Boris Ehrenstein, Florian Günther, Luise Rauch, Nadezhda Trendafilova, Dario Boschiero, Joachim Grifka, Martin Fleck

Erschienen in: Clinical Rheumatology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study is to investigate water compartments in patients with rheumatoid arthritis (RA). Acute inflammatory episodes such as infection stimulate water retention, chiefly implemented by the sympathetic nervous system (SNS) and hypothalamic-pituitary-adrenal (HPA) axis. This is an important compensatory mechanism due to expected water loss (sweating etc.). Since SNS and HPA axis are activated in RA, inflammation might be accompanied by water retention. Using bioimpedance analysis, body composition was investigated in 429 controls and 156 treatment-naïve RA patients between January 2008 and December 2014. A group of 34 RA patients was tested before and after 10 days of intensified therapy. Levels of pro-atrial natriuretic peptide (proANP) and expression of atrial natriuretic peptide in synovial tissue were investigated in 15 controls and 14 RA patients. Extracellular water was higher in RA patients than controls (mean ± SEM: 49.5 ± 0.3 vs. 36.7 ± 0.1, % of total body water, p < 0.0001). Plasma levels of proANP were higher in RA than controls. RA patients expressed ANP in synovial tissue, but synovial fluid levels and synovial tissue superfusate levels were much lower than plasma levels indicating systemic origin. Systolic/diastolic blood pressure was higher in RA patients than controls. Extracellular water levels did not change in RA patients despite 10 days of intensified treatment. This study demonstrates signs of intravascular overload in RA patients. Short-term intensification of anti-inflammatory therapy induced no change of a longer-lasting imprinting of water retention indicating the requirement of additional treatment. The study can direct attention to the area of volume overload.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kuis W, Jong-de Vos V, Sinnema G, Kavelaars A, Prakken B, Helders PM et al (1996) The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. Brain Behav Immun 10:387–398CrossRefPubMed Kuis W, Jong-de Vos V, Sinnema G, Kavelaars A, Prakken B, Helders PM et al (1996) The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. Brain Behav Immun 10:387–398CrossRefPubMed
2.
Zurück zum Zitat Perry F, Heller PH, Kamiya J, Levine JD (1989) Altered autonomic function in patients with arthritis or with chronic myofascial pain. Pain 39:77–84CrossRefPubMed Perry F, Heller PH, Kamiya J, Levine JD (1989) Altered autonomic function in patients with arthritis or with chronic myofascial pain. Pain 39:77–84CrossRefPubMed
3.
Zurück zum Zitat Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63–70PubMed Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63–70PubMed
4.
Zurück zum Zitat Dekkers JC, Geenen R, Godaert GL, van Doornen LJ, Bijlsma JW (2000) Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:465–467CrossRefPubMed Dekkers JC, Geenen R, Godaert GL, van Doornen LJ, Bijlsma JW (2000) Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:465–467CrossRefPubMed
5.
Zurück zum Zitat Catley D, Kaell AT, Kirschbaum C, Stone AA (2000) A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res 13:51–61CrossRefPubMed Catley D, Kaell AT, Kirschbaum C, Stone AA (2000) A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res 13:51–61CrossRefPubMed
6.
Zurück zum Zitat Schrier RW (2007) Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol 18:2028–2031CrossRefPubMed Schrier RW (2007) Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol 18:2028–2031CrossRefPubMed
7.
Zurück zum Zitat DiBona GF (2003) Neural control of the kidney: past, present, and future. Hypertension 41:621–624CrossRefPubMed DiBona GF (2003) Neural control of the kidney: past, present, and future. Hypertension 41:621–624CrossRefPubMed
8.
Zurück zum Zitat Giordano R, Di VL, Lanfranco F, Broglio F, Benso A, Gianotti L et al (2001) Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH(1–24). Clin Endocrinol (Oxf) 55:259–265CrossRef Giordano R, Di VL, Lanfranco F, Broglio F, Benso A, Gianotti L et al (2001) Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH(1–24). Clin Endocrinol (Oxf) 55:259–265CrossRef
9.
Zurück zum Zitat Lanfranco F, Gianotti L, Picu A, Fassino S, Abbate DG, Mondelli V et al (2004) The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa. J Endocrinol Investig 27:436–441CrossRef Lanfranco F, Gianotti L, Picu A, Fassino S, Abbate DG, Mondelli V et al (2004) The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa. J Endocrinol Investig 27:436–441CrossRef
10.
Zurück zum Zitat Shichiri M, Miyasaka N, Hirata Y, Ando K, Marumo F (1991) Appearance of beta-human atrial natriuretic peptide in collagen disease. J Endocrinol 130:159–161CrossRefPubMed Shichiri M, Miyasaka N, Hirata Y, Ando K, Marumo F (1991) Appearance of beta-human atrial natriuretic peptide in collagen disease. J Endocrinol 130:159–161CrossRefPubMed
11.
Zurück zum Zitat Yasuda M, Yasuda D, Tomooka K, Nobunaga M (1993) Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases. Clin Rheumatol 12:231–235CrossRefPubMed Yasuda M, Yasuda D, Tomooka K, Nobunaga M (1993) Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases. Clin Rheumatol 12:231–235CrossRefPubMed
12.
Zurück zum Zitat Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A et al (2008) Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 58:2662–2669CrossRefPubMedPubMedCentral Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A et al (2008) Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 58:2662–2669CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Peters MJ, Welsh P, McInnes IB, Wolbink G, Dijkmans BA, Sattar N et al (2010) Tumour necrosis factor blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study. Ann Rheum Dis 69:1281–1285CrossRefPubMed Peters MJ, Welsh P, McInnes IB, Wolbink G, Dijkmans BA, Sattar N et al (2010) Tumour necrosis factor blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study. Ann Rheum Dis 69:1281–1285CrossRefPubMed
14.
Zurück zum Zitat Francis GS, Felker GM, Tang WH (2016) A test in context: critical evaluation of natriuretic peptide testing in heart failure. J Am Coll Cardiol 67:330–337CrossRefPubMedPubMedCentral Francis GS, Felker GM, Tang WH (2016) A test in context: critical evaluation of natriuretic peptide testing in heart failure. J Am Coll Cardiol 67:330–337CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Palmer BF, Clegg DJ (2015) An emerging role of natriuretic peptides: igniting the fat furnace to fuel and warm the heart. Mayo Clin Proc 90:1666–1678CrossRefPubMed Palmer BF, Clegg DJ (2015) An emerging role of natriuretic peptides: igniting the fat furnace to fuel and warm the heart. Mayo Clin Proc 90:1666–1678CrossRefPubMed
16.
Zurück zum Zitat Tan AC, Jansen TL, Termond EF, Russel FG, Thien T, Kloppenborg PW et al (1992) Kinetics of atrial natriuretic peptide in young and elderly subjects. Eur J Clin Pharmacol 42:449–452PubMed Tan AC, Jansen TL, Termond EF, Russel FG, Thien T, Kloppenborg PW et al (1992) Kinetics of atrial natriuretic peptide in young and elderly subjects. Eur J Clin Pharmacol 42:449–452PubMed
17.
Zurück zum Zitat Provan S, Angel K, Semb AG, Atar D, Kvien TK (2010) NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study. Ann Rheum Dis 69:1946–1950CrossRefPubMed Provan S, Angel K, Semb AG, Atar D, Kvien TK (2010) NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study. Ann Rheum Dis 69:1946–1950CrossRefPubMed
18.
Zurück zum Zitat Mirjafari H, Welsh P, Verstappen SM, Wilson P, Marshall T, Edlin H et al (2014) N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). Ann Rheum Dis 73:684–690CrossRefPubMed Mirjafari H, Welsh P, Verstappen SM, Wilson P, Marshall T, Edlin H et al (2014) N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). Ann Rheum Dis 73:684–690CrossRefPubMed
19.
Zurück zum Zitat Tsigos C, Stefanaki C, Lambrou GI, Boschiero D, Chrousos GP (2015) Stress and inflammatory biomarkers and symptoms are associated with bio-impedance measures. Eur J Clin Investig 45:126–134CrossRef Tsigos C, Stefanaki C, Lambrou GI, Boschiero D, Chrousos GP (2015) Stress and inflammatory biomarkers and symptoms are associated with bio-impedance measures. Eur J Clin Investig 45:126–134CrossRef
20.
Zurück zum Zitat Ellis KJ (2000) Human body composition: in vivo methods. Physiol Rev 80:649–680PubMed Ellis KJ (2000) Human body composition: in vivo methods. Physiol Rev 80:649–680PubMed
21.
Zurück zum Zitat Lukaski HC, Bolonchuk WW, Hall CB, Siders WA (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60:1327–1332PubMed Lukaski HC, Bolonchuk WW, Hall CB, Siders WA (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60:1327–1332PubMed
22.
Zurück zum Zitat Heymsfield SB, Wang Z, Baumgartner RN, Ross R (1997) Human body composition: advances in models and methods. Annu Rev Nutr 17:527–558CrossRefPubMed Heymsfield SB, Wang Z, Baumgartner RN, Ross R (1997) Human body composition: advances in models and methods. Annu Rev Nutr 17:527–558CrossRefPubMed
23.
Zurück zum Zitat Wang Z, Heymsfield SB, Chen Z, Zhu S, Pierson RN (2010) Estimation of percentage body fat by dual-energy x-ray absorptiometry: evaluation by in vivo human elemental composition. Phys Med Biol 55:2619–2635CrossRefPubMedPubMedCentral Wang Z, Heymsfield SB, Chen Z, Zhu S, Pierson RN (2010) Estimation of percentage body fat by dual-energy x-ray absorptiometry: evaluation by in vivo human elemental composition. Phys Med Biol 55:2619–2635CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF et al (1995) Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9:20–25CrossRefPubMed Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF et al (1995) Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9:20–25CrossRefPubMed
25.
Zurück zum Zitat Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U et al (2010) Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957CrossRefPubMed Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U et al (2010) Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957CrossRefPubMed
26.
Zurück zum Zitat Avila-Diaz M, Ventura MD, Valle D, Vicente-Martinez M, Garcia-Gonzalez Z, Cisneros A et al (2006) Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 26:574–580PubMed Avila-Diaz M, Ventura MD, Valle D, Vicente-Martinez M, Garcia-Gonzalez Z, Cisneros A et al (2006) Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 26:574–580PubMed
27.
Zurück zum Zitat Kotanko P, Levin NW, Zhu F (2008) Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant 23:808–812CrossRefPubMed Kotanko P, Levin NW, Zhu F (2008) Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant 23:808–812CrossRefPubMed
28.
Zurück zum Zitat Crepaldi C, Lamas EI, Martino FK, Rodighiero MP, Scalzotto E, Wojewodzka-Zelezniakowicz M et al (2012) Bioimpedance and brain natriuretic peptide in peritoneal dialysis patients. Contrib Nephrol 178:174–181CrossRefPubMed Crepaldi C, Lamas EI, Martino FK, Rodighiero MP, Scalzotto E, Wojewodzka-Zelezniakowicz M et al (2012) Bioimpedance and brain natriuretic peptide in peritoneal dialysis patients. Contrib Nephrol 178:174–181CrossRefPubMed
29.
Zurück zum Zitat Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB (1992) Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 19:1505–1510PubMed Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB (1992) Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 19:1505–1510PubMed
30.
Zurück zum Zitat Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M et al (2008) Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 59:807–815CrossRefPubMedPubMedCentral Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M et al (2008) Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 59:807–815CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Bedogni G, Polito C, Severi S, Strano CG, Manzieri AM, Alessio M et al (1996) Altered body water distribution in subjects with juvenile rheumatoid arthritis and its effects on the measurement of water compartments from bioelectric impedance. Eur J Clin Nutr 50:335–339PubMed Bedogni G, Polito C, Severi S, Strano CG, Manzieri AM, Alessio M et al (1996) Altered body water distribution in subjects with juvenile rheumatoid arthritis and its effects on the measurement of water compartments from bioelectric impedance. Eur J Clin Nutr 50:335–339PubMed
32.
Zurück zum Zitat Lofthouse CM, Azad F, Baildam EM, Akobeng AK (2002) Measuring the nutritional status of children with juvenile idiopathic arthritis using the bioelectrical impedance method. Rheumatology (Oxford) 41:1172–1177CrossRef Lofthouse CM, Azad F, Baildam EM, Akobeng AK (2002) Measuring the nutritional status of children with juvenile idiopathic arthritis using the bioelectrical impedance method. Rheumatology (Oxford) 41:1172–1177CrossRef
33.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
34.
Zurück zum Zitat Fransen J, van Riel PL (2009) The disease activity score and the EULAR response criteria. Rheum Dis Clin N Am 35:745–viiiCrossRef Fransen J, van Riel PL (2009) The disease activity score and the EULAR response criteria. Rheum Dis Clin N Am 35:745–viiiCrossRef
35.
Zurück zum Zitat Straub RH, Rauch L, Fassold A, Lowin T, Pongratz G (2008) Neuronally released sympathetic neurotransmitters stimulate splenic interferon-gamma secretion from T cells in early type II collagen-induced arthritis. Arthritis Rheum 58:3450–3460CrossRefPubMed Straub RH, Rauch L, Fassold A, Lowin T, Pongratz G (2008) Neuronally released sympathetic neurotransmitters stimulate splenic interferon-gamma secretion from T cells in early type II collagen-induced arthritis. Arthritis Rheum 58:3450–3460CrossRefPubMed
36.
Zurück zum Zitat Stobaus N, Pirlich M, Valentini L, Schulzke JD, Norman K (2012) Determinants of bioelectrical phase angle in disease. Br J Nutr 107:1217–1220CrossRefPubMed Stobaus N, Pirlich M, Valentini L, Schulzke JD, Norman K (2012) Determinants of bioelectrical phase angle in disease. Br J Nutr 107:1217–1220CrossRefPubMed
37.
Zurück zum Zitat Lauridsen BK, Iversen K, Hunter I, Bay M, Kirk V, Nielsen OW et al (2013) ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study. BMJ Open 3, e003288CrossRefPubMedPubMedCentral Lauridsen BK, Iversen K, Hunter I, Bay M, Kirk V, Nielsen OW et al (2013) ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study. BMJ Open 3, e003288CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Kotyla PJ, Owczarek A, Rakoczy J, Lewicki M, Kucharz EJ, Emery P (2012) Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide. J Rheumatol 39:701–706CrossRefPubMed Kotyla PJ, Owczarek A, Rakoczy J, Lewicki M, Kucharz EJ, Emery P (2012) Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide. J Rheumatol 39:701–706CrossRefPubMed
39.
40.
Zurück zum Zitat Elkan AC, Engvall IL, Cederholm T, Hafstrom I (2009) Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 48:315–322CrossRefPubMed Elkan AC, Engvall IL, Cederholm T, Hafstrom I (2009) Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 48:315–322CrossRefPubMed
41.
Zurück zum Zitat Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM (2008) Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum 59:1407–1415CrossRefPubMedPubMedCentral Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM (2008) Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum 59:1407–1415CrossRefPubMedPubMedCentral
42.
43.
Zurück zum Zitat Schlaich MP, Krum H, Sobotka PA (2010) Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension. Curr Hypertens Rep 12:39–46CrossRefPubMed Schlaich MP, Krum H, Sobotka PA (2010) Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension. Curr Hypertens Rep 12:39–46CrossRefPubMed
44.
Zurück zum Zitat Sacco M, Meschi M, Regolisti G, Detrenis S, Bianchi L, Bertorelli M et al (2013) The relationship between blood pressure and pain. J Clin Hypertens (Greenwich) 15:600–605CrossRef Sacco M, Meschi M, Regolisti G, Detrenis S, Bianchi L, Bertorelli M et al (2013) The relationship between blood pressure and pain. J Clin Hypertens (Greenwich) 15:600–605CrossRef
45.
Zurück zum Zitat Struyf F, Meeus M (2014) Current evidence on physical therapy in patients with adhesive capsulitis: what are we missing? Clin Rheumatol 33:593–600CrossRefPubMed Struyf F, Meeus M (2014) Current evidence on physical therapy in patients with adhesive capsulitis: what are we missing? Clin Rheumatol 33:593–600CrossRefPubMed
46.
Zurück zum Zitat Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R (2006) Increased neural sympathetic activation in fibromyalgia syndrome. Ann N Y Acad Sci 1069:109–117:109–117CrossRefPubMed Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R (2006) Increased neural sympathetic activation in fibromyalgia syndrome. Ann N Y Acad Sci 1069:109–117:109–117CrossRefPubMed
47.
Zurück zum Zitat Bomholt SF, Harbuz MS, Blackburn-Munro G, Blackburn-Munro RE (2004) Involvement and role of the hypothalamo-pituitary-adrenal (HPA) stress axis in animal models of chronic pain and inflammation. Stress 7:1–14CrossRefPubMed Bomholt SF, Harbuz MS, Blackburn-Munro G, Blackburn-Munro RE (2004) Involvement and role of the hypothalamo-pituitary-adrenal (HPA) stress axis in animal models of chronic pain and inflammation. Stress 7:1–14CrossRefPubMed
48.
Zurück zum Zitat Grossman E, Messerli FH (2012) Drug-induced hypertension: an unappreciated cause of secondary hypertension. Am J Med 125:14–22CrossRefPubMed Grossman E, Messerli FH (2012) Drug-induced hypertension: an unappreciated cause of secondary hypertension. Am J Med 125:14–22CrossRefPubMed
49.
Zurück zum Zitat Titze J, Dahlmann A, Lerchl K, Kopp C, Rakova N, Schroder A et al (2014) Spooky sodium balance. Kidney Int 85:759–767CrossRefPubMed Titze J, Dahlmann A, Lerchl K, Kopp C, Rakova N, Schroder A et al (2014) Spooky sodium balance. Kidney Int 85:759–767CrossRefPubMed
50.
Zurück zum Zitat Coderre TJ, Chan AK, Helms C, Basbaum AI, Levine JD (1991) Increasing sympathetic nerve terminal-dependent plasma extravasation correlates with decreased arthritic joint injury in rats. Neuroscience 40:185–189CrossRefPubMed Coderre TJ, Chan AK, Helms C, Basbaum AI, Levine JD (1991) Increasing sympathetic nerve terminal-dependent plasma extravasation correlates with decreased arthritic joint injury in rats. Neuroscience 40:185–189CrossRefPubMed
Metadaten
Titel
Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients—signs of volume overload
verfasst von
Rainer H. Straub
Boris Ehrenstein
Florian Günther
Luise Rauch
Nadezhda Trendafilova
Dario Boschiero
Joachim Grifka
Martin Fleck
Publikationsdatum
26.04.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 5/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3286-x

Weitere Artikel der Ausgabe 5/2017

Clinical Rheumatology 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.